Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02061787 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

Study acronym: CPETPH
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv8
  2. Notable Primary endpoints: 1 to 3
    • Interventions: balloon pulmonary angioplasty (Device)
    • Study description expanded, about 31 words
    v7
  3. Notable Enrollment target: 300 to 4000
    • Primary and study completion dates: Dec 31, 2018 to Sep 8, 2030
    v6
  4. Notable Primary and study completion dates: Dec 31, 2017 to Dec 31, 2018
    • Secondary endpoints: details revised at 1 of 1 entry
    v5
  5. Notable Primary and study completion dates: Dec 2016 to Dec 31, 2017v4
Show 2 earlier versionsHide 2 earlier versions
  1. Minor Re-verified, no change to tracked fieldsv3
  2. Notable Primary and study completion dates: Sep 2015 to Dec 2016v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment
Trial Details
NCT Number NCT02061787
Lead Sponsor Chinese Pulmonary Vascular Disease Research Group
Conditions
(from sponsor)
Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
Related terms Hypertension, Pulmonary, Pulmonary Arterial Hypertension
Enrollment 4,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov